Gadaleta, Raffaella M

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 870

Gut microbiota in the pathogenesis and therapeutic approaches of diabetes

Crudele, L., Gadaleta, R. M., Cariello, M., & Moschetta, A. (2023) · eBioMedicine

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 251

Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease

Nijmeijer, R. M., Gadaleta, R. M., van Mil, S. W. C., van Bodegraven, A. A., Crusius, J. B. A., Dijkstra, G., Hommes, D. W., de Jong, D. J., Stokkers, P. C. F., Verspaget, H. W., et al. (2011) · PLoS ONE

Inflammatory Bowel DiseaseGut microbiota and health

Cited by 119